Ascites (malignant)

Definition

Ascites is a central oedema in which fluid accumulates in the peritoneal cavity (Witte and Witte [309]). Abdominal paracentesis is a technique used to drain a pathological collection of ascitic fluid from the abdomen (Campbell [28]). This technique is performed to help diagnose the cause of ascites (diagnostic paracentesis) or to relieve the discomfort associated with this condition (therapeutic paracentesis) (McGibbon et al. [175]).

Anatomy and physiology

The peritoneum is a semi‐permeable serous membrane consisting of two separate layers: the parietal layer and the visceral layer. The parietal layer covers the abdominal and pelvic walls and the undersurface of the diaphragm. The visceral layer lines and supports the abdominal organs and the parietal peritoneum (Figure 26.8). The space between the parietal and visceral layers is known as the peritoneal cavity (Thibodeau and Patton [281]). The normal peritoneal cavity contains a small amount of free fluid – approximately 50 mL (McGibbon et al. [175]).
image
Figure 26.8  Peritoneum of female in lateral view. Source: Dougherty and Lister ([64]). Reproduced with permission from John Wiley & Sons.
In a healthy individual, around 50–100 mL of fluid passes every hour from the peritoneal cavity into the lymphatic vessels and through the lymphatic vessels in the diaphragm due to changes in pressure as a result of breathing (Bronskill et al. [25]). The fluid is produced from the capillaries lining the peritoneal cavity and is drained by lymphatic vessels under the diaphragm. The fluid is collected by the right lymphatic duct which drains into the vena cava. The peritoneum forms the largest serous membrane in the body (Tortora and Derrickson [285]). However, in patients with malignant ascites, this balance of production and drainage is disrupted and ascitic fluid collects in the peritoneal cavity (Box 26.2).
Box 26.2
Functions of the peritoneum
  • The peritoneum is a serous membrane that enables the abdominal contents to glide over each other without friction.
  • It forms a partial or complete cover for the abdominal organs.
  • It forms ligaments and mesenteries that help to keep the organs in position.
  • The mesenteries contain fat and act as a store for the body.
  • The mesenteries can move to engulf areas of inflammation and this prevents the spread of infection.
  • It has the power to absorb fluids and exchange electrolytes.
Source: Adapted from Thibodeau and Patton ([281]), Tortora and Derrickson ([285]).

Related theory

Ascites can be caused by non‐malignant conditions such as cirrhosis of the liver, advanced congestive heart failure, chronic pericarditis and nephrotic syndrome (Hou and Sanyal [113], Sargent [264]). In the absence of malignancy, liver disease is responsible for over 80% of cases of ascites (Royal College of Obstetricians and Gynaecologists [256]). Malignant conditions such as metastatic cancer of the ovary, stomach, colon or breast can also cause ascites. If a definitive diagnosis is needed to establish the cause, to aid staging and possible surgical intervention, then a peritoneal tap and analysis of fluid will be useful (Marincola and Schwartzentruber [164]).
It is not possible to distinguish between malignant and benign ascites by physical examination or radiographic techniques so invasive testing is necessary to differentiate the two types (Sangisetty and Miner [262]).
The pathogenesis of ascites differs depending on its primary related factors. Cirrhotic ascites is believed to be related to portal hypertension (Hou and Sanyal [113], Lee and Grap [138]). The increased pressure occurs due to fibrosis and scarring of the liver from chronic liver disease, causing obstruction to venous flow (Whiteman and McCormick [305]). In the case of heart failure and constrictive pericarditis, the heart loses its ability to pump blood and this causes a back‐up of blood and increases pressure in the portal venous system, leading to portal hypertension and ascites (Lee and Grap [138]).
The underlying physiological process causing malignant ascites is often multifactorial and is not as well understood as non‐cancer‐related ascites (Seike et al. [268]). It is thought to be caused by obstruction of lymphatic drainage preventing absorption of intra‐abdominal fluid and protein, producing a high volume of fluid with a high protein content, hypoproteinaemia and occasionally portal hypertension secondary to hepatic cancer. This is thought to be the result of cytokines, mechanical obstruction and hormonal influence. Cytokines such as VEGF and vascular permeability factor regulate vascular permeability. The obstruction of lymphatic drainage by the disseminating malignant cells in the peritoneal cavity reduces absorption of peritoneal exudates (Seike et al. [268]). This reduction activates the renin–angiotensin–aldosterone system and leads to sodium retention, which then further exacerbates the ascites.
Ascites can be split into two main groups: exudates, which are high in protein, and transudates, which are low in protein (Runyon et al. [260], Witte and Witte [309]). Exudates are more common and derive from a combination of increased permeability of capillaries and lymphatic obstruction, whereas transudates are likely to arise where liver metastases cause portal hypertension. Non‐malignant ascites is more likely to produce a transudative ascites in which there is a marked increase in production of fluid and the lymphatic system reaches capacity with flow rates of 200 mL of ascites per hour (Bronskill et al. [25]). Ascites resulting from compression of the hepatic vein causing portal hypertension will also produce a transudative ascites. In malignancy that has spread to the peritoneal cavity, an exudative ascites is produced and lymphatic flow markedly decreases to levels as low as 15 mL per hour as the lymphatic vessels have become obstructed by tumour and cannot cope with the increased permeability of blood vessels, hence fluid accumulates.
Ascites is often accompanied by debilitating symptoms as large amounts of fluid collect in the peritoneal cavity, causing an increase in intra‐abdominal pressure and resulting in pressure on internal structures. The fluid accumulation may occur over several weeks or rapidly over a few days (Lee and Grap [138]). Symptoms initially include vague abdominal discomfort, which can go on to affect the respiratory and gastrointestinal systems, depending on the amount of fluid present. Pressure on the diaphragm decreases the intrathoracic space and causes shortness of breath. Gastric pressure may cause anorexia, indigestion or hiatus hernia. Intestinal pressure may result in constipation, bowel obstruction or decreased bladder capacity (Royal College of Obstetricians and Gynecologists [256]). Patients also become increasingly fatigued, finding simple daily tasks difficult (Slusser [273]). Additionally, body image can be affected even when minimal distension is present.
Malignant ascites is most commonly seen in patients with a known diagnosis of ovarian or gastrointestinal cancer, but it can occur in any oncology patient (Ayantunde and Parsons [9]). Cytological confirmation of malignant cells is, however, difficult, with only a 50% chance of success (Fentiman [76]). In addition, more than 50% of patients with malignant ascites present with ascites at the initial diagnosis of their cancer (Ayantunde and Parsons [9]).
The onset and progression of malignant ascites is associated with deterioration in quality of life and a poor prognosis. Ascites is rarely an emergency but can be extremely uncomfortable for patients and it is not uncommon for over 8 litres of fluid to accumulate (Ayantunde and Parsons [10]). Ascites accumulates due to the presence of widespread peritoneal deposits, which leak fluid, and in some cases involvement of retroperitoneal nodes by disease may prevent drainage. Patients may complain of abdominal distension, pain, breathlessness, nausea and vomiting.
Abdominal paracentesis (drainage) will provide symptomatic relief in over 90% of cases, often very rapidly (Ayantunde and Parsons [10]). In a patient who has had no prior abdominal surgery, who is in significant pain and distress and who has a large volume of ascites, blind drainage is acceptable, however ultrasound marking is preferable. Paracentesis is effective in relieving the symptoms associated with malignant ascites but it requires repeated treatments, leads to frequent hospitalizations, depletes the patient of protein and electrolytes, and exposes the patient to a small but significant risk of peritonitis (Royal College of Obstetricians and Gynaecologists [256]).

Evidence‐based approaches

Rationale

There is much debate about whether it is safe to drain large volumes of fluid rapidly from the abdomen. One concern is that profound hypotension may follow because of the sudden release of intra‐abdominal pressure and consequent possible vasodilation (Lee et al. [139]). However, it is suggested that up to 5 litres of fluid may be safely drained over a few hours and it is not necessary to drain the abdomen until dry (Pericleous et al. [227], Stephenson and Gilbert [277]). In cases of cirrhosis, however, Moore and Aithal ([187]) suggest that all fluid should be drained to dryness in a single session as rapidly as possible over 1–4 hours, assisted by gentle mobilization of the cannula or turning the patient on their side if needed.
It is generally not necessary to have intravenous fluid or albumin replacement. However, patients with ascites who have large tumours, cirrhosis of the liver or renal impairment may require slower drainage of fluid and possible fluid replacement, depending on their clinical condition. Abdominal and peritoneal tumours can cause ascites to develop independently of the circulatory system and therefore hypotension is not usually seen as the ascites is drained.
A small study has shown that the success of blind paracentesis is directly related to the amount of fluid present (44% with 300 mL and 78% with 500 mL) (McGibbon et al. [175]). The literature suggests the use of ultrasound‐guided paracentesis to confirm the presence of ascites and also to identify the best site to perform paracentesis, particularly when a small amount of fluid is present (McGibbon et al. [175]).

Indications

  • To obtain a specimen of fluid for analysis for diagnostic purposes (diagnostic paracentesis).
  • To relieve the symptoms associated with ascites, both physical and psychological (therapeutic paracentesis).
  • To administer substances such as cytotoxic drugs (e.g. bleomycin, cisplatin) or other agents into the peritoneal cavity, to achieve regression of serosal deposits responsible for fluid formation (Hosttetter et al. [112]).

Contraindications

  • Relative contraindications: pregnancy, severe bowel distension and previous extensive abdominal or pelvic surgery (McGibbon et al. [175]). When relative contraindications are present, paracentesis without the assistance of ultrasound (blind paracentesis) is not recommended (McGibbon et al. [175]).
  • Absolute contraindication: clinically evident fibrinolysis or disseminated intravascular coagulation (McGibbon et al. [175]).

Preparatory investigations

The patient's clinical condition and purpose of the procedure must be taken into account when deciding what investigations are necessary but pre‐procedure investigations usually include a blood screen and ultrasound examination. To keep intrusion to a minimum for palliative patients, fewer investigations may be performed. Blood is usually checked for FBC, U&Es, creatinine, LFTs, plasma proteins and coagulation screen (Rull [257]). In the case of a diagnostic paracentesis, the ascitic fluid should be analysed for cell count, bacterial culture, total protein and albumin (Hou and Sanyal [113]).

Methods of managing ascites

Interventions used to treat ascites range from an aggressive approach to a purely palliative approach. There have been few definitive studies that have evaluated the different approaches in the treatment of malignant ascites (Hosttetter et al. [112]). While paracentesis is effective, ascites recurs, requiring repeated procedures. This imposes a further burden on patients and their families (Mercadante et al. [178]). Methods for treating ascites may include the use of diuretics, paracentesis and a diet low in sodium, instillation of peritoneal agents or the insertion of long‐term catheters (Ayantunde and Parsons [10]).
In terms of the use of drains, there is no consensus in the literature in relation to how long the drain should stay in place, whether the volume of fluid drained should be replaced intravenously, whether the drain should be clamped to regulate the drainage of fluid and whether any vital observations should be regularly recorded (Keen et al. [132]). However, many UK guidelines (London Cancer Alliance [151]) suggest that the ascites can be left to drain freely; clamping of the tube is not necessary unless the patient becomes hypotensive, in which case the drain is clamped for 20 minutes. The blood pressure should then be checked before further drainage.
In practice, most local guidelines suggest draining 1 litre, then clamping before checking the blood pressure. If the patient is not hypotensive (systolic  <  90) then drainage can continue and this process should be repeated after every litre drained. There is no evidence that albumin support is beneficial and intravenous fluids are only used if the patient becomes hypotensive despite clamping the drain (Moore and Aithal [187]). The evidence suggests that drainage limited to 5–8 litres provides the greatest symptomatic relief and a reduction in potential complications. This evidence makes day case paracentesis a preferred option for many patients (Becker et al. [13]).
In chronic management, ascites frequently reaccumulates and drainage tends to provide ever‐decreasing symptomatic benefit, but it is still worth performing. With recurrent drainage, there is an increasing risk that the ascites can become loculated, therefore a more permanent drain such as a PleurX™ may be appropriate (NICE [210]). Types of catheters are discussed further under ‘Equipment’.
Common interventions in ascites include:
  • Paracentesis: This is the most common way of managing ascites as it has an immediate effect in 90% of cases (Campbell [28], Marincola and Schwartzentruber [164]).
  • Sodium‐restricted diet. The amount of fluid retained in the body depends on the balance between sodium ingested in the diet and sodium excreted in the urine. A reduced sodium intake of 2 g per day is considered a realistic goal (Sargent [264]).
  • Diuretics. There is limited evidence supporting a role for diuretics such as spironolactone in malignant ascites, with only a handful of small case series reporting the outcomes after oral or intravenous therapy (Royal College of Obstetricians and Gynaecologists [256]). However, surveys of clinical practice suggest that diuretics are commonly used and are useful mainly in cirrhotic‐type ascites. They may be used for malignant ascites together with a restriction of salt and fluid intake, and have been found to be effective in about one‐third of patients (Hosttetter et al. [112], Sangisetty and Miner [262]). Pockros et al. ([234]) suggested that diuretic therapy was unlikely to mobilize ascitic fluid and that any weight loss was from loss of fluid outside of the peritoneal cavity and could lead to patients becoming dehydrated if not carefully supervised. Spironolactone is the diuretic of choice (Hou and Sanyal [113]). The most effective way of monitoring the fluid loss is by weighing the patient daily (Sargent [264]).
  • Instillation of intraperitoneal agents. Cytotoxics, sclerosants and biological substances have been tried in an attempt to control the recurrence of ascites. To date, intraperitoneal agents have not been proven, unequivocally, to have a greater beneficial effect than the use of diuretics (Fentiman [76]).
It should however be noted that the literature available is mostly generated from studies in patients suffering from acute or chronic liver failure; this should be taken into account when managing patients with non‐malignant ascites.

Anticipated patient outcomes

Nursing and medical care of patients with malignant abdominal ascites should be aimed at improving quality of life by relieving suffering caused by the symptoms (Cope [46]). Each patient should be carefully assessed with consideration of their individual circumstances, maintaining respect for their wish to have or not to have interventional treatment (Campbell [28]).
For many patients accumulation of ascitic fluid is a poor prognostic indicator and therefore the management is palliative (Ayantunde and Parsons [10]).

Legal and professional issues

Nurses should ensure that patients are educated about the nature of the procedure, what results can realistically be expected, and the risks and benefits. It is essential that the patient, family and carer are involved in the discussion so that an informed and joint decision may be made in order to achieve the best possible outcome.

Competencies

The procedure is performed by a doctor or a practitioner trained in paracentesis assisted by a nurse or healthcare professional throughout. There is no accredited pathway or course for learning this clinical skill and specific training has to be negotiated and developed locally (Vaughan [298]).

Assessment

Clinical examination usually suffices; however, it is rare to be able to detect ascites unless there are at least 2–3 litres present. It is common practice to perform paracentesis under ultrasound control to identify the deepest pool of fluid and to ensure that there are no vital organs beneath the drainage site. A drainage catheter is usually placed following an ultrasound to mark an appropriate area into which it can be introduced. The catheter can be inserted at the same time as the scan or, more commonly, afterwards on the ward. The period between drainage and ultrasound can be a few hours, in which case the bowel may have moved, making bowel perforation an increased risk (Royal College of Obstetricians and Gynaecologists [256]). Abdominal X‐ray is not useful in this setting unless it is needed to exclude small bowel obstruction (Sangisetty and Miner [262]).

Pre‐procedural considerations

Equipment

Three types of long‐term catheter are generally used:
  • Peritoneovenous shunt: generally used in patients with a long‐term prognosis. These shunts drain ascitic fluid into the superior vena cava and require general anaesthesia for insertion (Mamada et al. [161], Seike et al. [268]).
  • PleurX™ drain: a tunnelled catheter placed under ultrasound and fluoroscopic guidance. This device is associated with low rates of serious adverse clinical events, catheter failure, discomfort and electrolyte imbalance (Courtney et al. [49]). Additionally, it may allow patients to avoid spending added time in hospital for repeated paracentesis.
  • Peritoneal port‐catheter: similar to but larger than central venous access ports in order to make access easier and to decrease possible catheter occlusion (Ozkan et al. [221]). There are a very limited number of studies supporting its use.
Nurses should describe the equipment to be used during paracentesis to the patient. This may be more relevant when looking after a patient undergoing the procedure for the first time to whom the size of the catheter may be concerning.

Assessment and recording tools

A detailed and consistent nursing assessment is important when caring for patients requiring paracentesis. Nurses should pay attention to the cause of the ascites and the frequency with which the procedure is occurring. The involvement of the palliative care team may be indicated at this stage. In cases of ascites secondary to cirrhosis, nurses should pay special attention to unresolved issues surrounding alcohol abuse, offering support and information to the patient and family. As well as assessing the patient's psychological well‐being, nurses must pay attention to the skin condition and pain levels.
In preparation for the paracentesis, the following investigations should take place to ensure patient safety: a full set of observations and baseline blood tests (FBC, U&Es and clotting). It is recommended that platelets are >  50  ×  109/L and international normalized ratio (INR) 5 L/24 hours (NICE 2012d). However, an abnormal INR or thrombocytopenia is not a contraindication to paracentesis, and in most patients there is no need to transfuse fresh frozen plasma or platelets prior to the procedure (Runyon [258]). Of patients with ascites, 70% have an abnormal prothrombin time, but the actual risk of bleeding following paracentesis is very low (less than 1% of patients require transfusion). Exceptions are patients with clinically apparent disseminated intravascular coagulation or clinically apparent hyperfibrinolysis, who require treatment to decrease their risk of bleeding before undergoing paracentesis (McVay and Toy [177]). The patient's girth around the umbilicus should be measured and weight checked before the procedure; this should be clearly documented to allow for subsequent comparisons to be made. There is no need for the patient to fast prior to this procedure.

Pharmacological support

The healthcare professional performing the paracentesis must use a local anaesthetic (e.g. lidocaine 1%). The lidocaine is injected subcutaneously initially with a 25 G needle and subsequently with a 23 G needle until optimal pain control is achieved, not exceeding the maximum dose of 4.5 mg/kg (or 200 mg). Optimal pain control is achieved between 2 and 5 minutes after the drug is injected and it is important for the practitioner to assess the effectiveness of the local anaesthetic before the insertion of the catheter and drainage of ascites. Lorazepam at a dose of 1 mg can be of benefit prior to the procedure for patients who are anxious, due to its muscle relaxant and anxiolytic effects (Joint Formulary Committee [122]).

Non‐pharmacological support

The nurse should enquire about the patient's fears and concerns regarding paracentesis. For some patients, music or relaxation, physical relaxation and visualization techniques are of great benefit so use of these approaches should be considered, if available (Misra [184]).
Procedure guideline 26.2
Table 26.15  Prevention and resolution (Procedure guideline 26.2)
ProblemCausePreventionSuggested action
Patient exhibits shock.Major circulatory shift of fluid or sudden release of intra‐abdominal pressure, vasodilation and subsequent lowering of blood pressure.Monitor blood pressure and consider administration of intravenous fluid if volumes larger than 5 litres are expected to drain.Clamp the drainage tube with a gate clamp to prevent further fluid loss. Record the patient's vital signs. Refer to the medical staff for immediate intervention.
Cessation of drainage of ascitic fluid.Abdomen is empty of ascitic fluid. 
Check the total output of ascitic fluid given on the patient's fluid balance chart.
Ask the patient to move around to stimulate fluid movement within the peritoneal cavity.
Measure the patient's girth; compare this measurement with the pre‐abdominal paracentesis measurement. Suggest to medical staff that the cannula should be removed. Discontinue the drainage system.
 Patient's position is inhibiting drainage.Teach the patient to avoid exerting pressure on the drainage tubing.Change the patient's position, that is, move the patient upright or onto their side to encourage flow by gravity. Encourage the patient to mobilize.
 The ascitic fluid has congealed in the drainage system.Keep the drainage bag on a stand and lower than the puncture site to facilitate drainage by gravity.‘Milk’ the tubing. If this is unsuccessful, change the drainage system aseptically. Refer to the medical staff.
Cannula becomes dislodged.Ineffective dressing or trauma at the puncture site.Collaborate with medical staff about applying a suture or alternatively apply a secure dressing. The tube is taped to the skin further down to prevent pulling with movement at the puncture site.Apply a secure dry dressing. Reassure the patient. Inform the medical staff. US may be required to confirm that the tube is in position.
Pain.Pressure of ascites or position of drain.Offer analgesia 30 minutes prior to procedure. Apply a dressing, allowing enough padding around the puncture site but avoiding drain movement within the abdomen.Identify the cause. Anchor the drain securely to avoid pulling at the insertion site or movement within the abdomen. Assist the patient with repositioning. Administer an appropriate prescribed analgesic, monitor the patient's response and inform medical staff.
image
Figure 26.9  Example of sterile equipment tray for abdominal paracentesis. Source: Dougherty and Lister ([64]). Reproduced with permission from John Wiley & Sons.

Post–procedural considerations

After paracentesis patients show relief of nausea, vomiting, dyspnoea and/or abdominal discomfort (Sangisetty and Miner [262]). Information should be given about post‐procedure care of the puncture site and about the importance of diet and fluid intake to replace proteins and fluid lost in the ascitic fluid.

Complications

Complications of ascitic drains include pain, wound infection, leak from the puncture site, perforation, hypotension and secondary peritonitis (Duggal et al. [65]). In a study of 171 patients, major complications were seen in 1.6% and tended to be associated with a low platelet count (<  50  ×  109/L) or alcoholic cirrhosis (De Gottardi et al. [54]).